{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:42:47Z","timestamp":1793241767074,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1206000"],"award-info":[{"award-number":["2022YFA1206000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52473142"],"award-info":[{"award-number":["52473142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52033006"],"award-info":[{"award-number":["52033006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jconrel.2025.113764","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T11:56:25Z","timestamp":1745322985000},"page":"113764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Polymersome-enabled brain codelivery of STAT3 siRNA and CpG oligonucleotide boosts chemo-immunotherapy of malignant glioma"],"prefix":"10.1016","volume":"383","author":[{"given":"Songsong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113764_bb0005","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.113764_bb0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","article-title":"Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours","volume":"18","author":"Horbinski","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2025.113764_bb0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-024-01763-x","article-title":"Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis","volume":"9","author":"Yan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113764_bb0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2021.01.012","article-title":"Frontiers in the treatment of glioblastoma: past, present and emerging","volume":"171","author":"Janjua","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113764_bb0025","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.113764_bb0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41467-019-14036-x","article-title":"Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways","volume":"11","author":"Meng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113764_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg5553","article-title":"Reactivating PTEN to impair glioma stem cells by inhibiting cytosolic iron-sulfur assembly","volume":"16","author":"Yin","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.113764_bb0040","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.abn7570","article-title":"Mechanism-based design of agents that selectively target drug-resistant glioma","volume":"377","author":"Lin","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.113764_bb0045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/acsnano.2c10219","article-title":"Immune exosomes loading self-assembled Nanomicelles traverse the blood-brain barrier for chemo-immunotherapy against glioblastoma","volume":"17","author":"Cui","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113764_bb0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jconrel.2022.03.050","article-title":"In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma","volume":"345","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113764_bb0055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41467-020-20599-x","article-title":"Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma","volume":"12","author":"Agliardi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113764_bb0060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41565-020-00843-7","article-title":"Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection","volume":"16","author":"Zhang","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.113764_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41467-023-35957-8","article-title":"Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113764_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jconrel.2024.01.034","article-title":"Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer","volume":"367","author":"Memari","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113764_bb0075","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/cas.12724","article-title":"Immunotherapy with CpG-ODN in neoplastic meningitis: a phase I trial","volume":"106","author":"Ursu","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2025.113764_bb0080","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2025.113764_bb0085","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-18-1140","article-title":"Rindopepimut with bevacizumab for patients with relapsed EGFRvIII-expressing glioblastoma (ReACT): results of a double-blind randomized phase II trial","volume":"26","author":"Reardon","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113764_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113764_bb0095","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41578-024-00684-z","article-title":"Engineering nanomaterials for glioblastoma nanovaccination","volume":"9","author":"Hameedat","year":"2024","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113764_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-022-01260-z","article-title":"Signaling pathways in brain tumors and therapeutic interventions","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113764_bb0105","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41590-023-01605-y","article-title":"Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma","volume":"24","author":"Pang","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.113764_bb0110","article-title":"SHF acts as a novel tumor suppressor in glioblastoma Multiforme by disrupting STAT3 dimerization","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113764_bb0115","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/1878-0261.13263","article-title":"Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis","volume":"16","author":"Li","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jconrel.2025.113764_bb0120","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-023-40270-5","article-title":"Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113764_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103689","article-title":"Immunotherapy of malignant glioma by noninvasive administration of TLR9 agonist CpG Nano-Immunoadjuvant","volume":"9","author":"Wei","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113764_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2022.04.048","article-title":"ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy","volume":"347","author":"Wei","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113764_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood-2013-07-517987","article-title":"Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity","volume":"123","author":"Hossain","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.113764_bb0140","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ymthe.2018.01.007","article-title":"B cell lymphoma immunotherapy using TLR9-targeted oligonucleotide STAT3 inhibitors","volume":"26","author":"Zhao","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.113764_bb0145","article-title":"In situ tumor vaccination with nanoparticle co-delivering CpG and STAT3 siRNA to effectively induce whole-body antitumor immune response","volume":"33","author":"Ngamcherdtrakul","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113764_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.omtn.2021.12.029","article-title":"Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells","volume":"27","author":"Adamus","year":"2022","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.jconrel.2025.113764_bb0155","article-title":"Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113764_bb0160","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","article-title":"Brain-targeted codelivery of Bcl-2\/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113764_bb0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.actbio.2023.05.001","article-title":"Reversing immune evasion using a DNA nano-orchestrator for pancreatic cancer immunotherapy","volume":"166","author":"Zhao","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.113764_bb0170","article-title":"Biomimetic targeting nanoadjuvants for sonodynamic and chronological multi-immunotherapy against holistic biofilm-related infections","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113764_bb0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/cancers13030437","article-title":"The role and therapeutic targeting of JAK\/STAT signaling in glioblastoma","volume":"13","author":"Ou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2025.113764_bb0180","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1158\/1078-0432.CCR-22-3273","article-title":"Dual role of CXCL8 in maintaining the mesenchymal state of glioblastoma stem cells and M2-like tumor-associated macrophages","volume":"29","author":"Yuan","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113764_bb0185","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.113764_bb0190","article-title":"3D-bioprinted Mini-brain: a glioblastoma model to study cellular interactions and therapeutics","volume":"31","author":"Heinrich","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113764_bb0195","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2022.03.036","article-title":"Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy","volume":"345","author":"Rehman","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113764_bb0200","first-page":"8","article-title":"Targeting immunogenic cell death for glioma immunotherapy, trends","volume":"10","author":"Mishchenko","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.113764_bb0205","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1021\/acsnano.3c11189","article-title":"Antigen self-presented personalized nanovaccines boost the immunotherapy of highly invasive and metastatic tumors","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113764_bb0215","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-20-3760","article-title":"Opening of the blood-brain barrier using low-intensity pulsed ultrasound enhances responses to immunotherapy in preclinical glioma models","volume":"27","author":"Sabbagh","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113764_bb0220","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113764_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccell.2022.12.007","article-title":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors","volume":"41","author":"Kilian","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113764_bb0230","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.apsb.2021.12.019","article-title":"Therapeutic strategies of glioblastoma (GBM): the current advances in the molecular targets and bioactive small molecule compounds","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.113764_bb0235","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-23-0388","article-title":"Safety and efficacy of anlotinib hydrochloride plus temozolomide in patients with recurrent glioblastoma","volume":"29","author":"Xu","year":"2023","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925003840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925003840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:25:11Z","timestamp":1762269911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925003840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"alternative-id":["S0168365925003840"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113764","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymersome-enabled brain codelivery of STAT3 siRNA and CpG oligonucleotide boosts chemo-immunotherapy of malignant glioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113764"}}